Medicines and older people: Polypharmacy, adherence and safety

References

• Sabate E., editor. Adherence to long term therapies: evidence for action. Geneva: World Health Organisation; 2003. p. 1–209.
   Google Scholar
• Diabetes Australia (DA). A new language for diabetes: improving communication with and about people with diabetes. Canberra, DA: Diabetes Australia; 2011.
   Google Scholar
• Diabetes Control and Complications Trial research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New Engl J Med. 1993;329:977–86. doi: 10.1056/NEJM199309303291401
   Google Scholar
• United Kingdom Prospective Study (UKPDS 33, 34). Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with Type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–53, 854–65. doi: 10.1016/S0140-6736(98)07019-6
   Google Scholar
• American Diabetes Association (ADA). 2016. Standards of medical care in Diabetes care.diabetesjournals.org/content/suppl/ … 1 … /2016-Standards-of-Care.pdf
   Google Scholar
• Dunning T, Manias E. Medication knowledge and self-management by people with Type 2 diabetes. Aust J Adv Nurs. 2005;11:172–81.
   Google Scholar
• Dunning T, Savage S, Duggan N, Martin P. The experiences and care preferences of people with diabetes at the end of life. J Hosp Palliat Nurs. 2012;14(4):293–302.
   Google Scholar
• Mosby’s Medical Dictionary. 2009. 8th ed. Elservier.
   Google Scholar
• Wise J. Polypharmacy: a necessary evil. Brit Med J. 2013. doi:10.1136/bmj.17033.
   Google Scholar
• Byatt K. Polypharmacy: thoughtful or random? Brit Med J. 2014;348:g17. doi: 10.1136/bmj.g17
   Google Scholar
• Austin R. Polypharmacy as a risk factor in the treatment of Type 2 diabetes. Diabetes Spectr. 2006;19(1):13–6. doi: 10.2337/diaspect.19.1.13
   Google Scholar
• Green J, Hawley J, Rask K. Is the number of prescribing physicians an independent risk factor for adverse drug events in an elderly outpatient population? Am J Geriatr Pharmac. 2007;5(1):31–9. doi: 10.1016/j.amjopharm.2007.03.004
   Google Scholar
• Jenkins R, Vaida A. Simple strategies to avoid medication errors. AAFP; 2007. http://www.aafp.org/fpm/2007/0200p41.html (accessed December 2009).
   Google Scholar
• Gnjidic D, Hilmer S, Blyth F, Naganathan V, Waite L, Seibel MJ, et al. Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J Clin Epidemiol. 2012;65:989–95. doi: 10.1016/j.jclinepi.2012.02.018
   Google Scholar
• Berenznicki L, Peterson G. Adverse drug events and the role of pharmacy. Pharmacist. 2008;27(9):750–56.
   Google Scholar
• Roughead E., Lexchin J. Adverse drug events: counting is not enough, action is needed. Med J Australia. 2006;184(7):315–6.
   Google Scholar
• Von Laue N, Schwappach D, Koeck C. The epidemiology of preventable adverse drug events: a review of the literature. Wien Klin Wochenschr. 2003;115:407–15. doi: 10.1007/BF03040432
   Google Scholar
• Gandhi T, Weingart S, Borus J, Seger AC, Peterson J, Burdick E, et al. Adverse drug events in ambulatory care. New Engl J Med. 2003;348:1556–64. doi: 10.1056/NEJMsa020703
   Google Scholar
• Institute of Safe Medicine Practice (ISMP). 2008. www.ismp.org (accessed January 2011).
   Google Scholar
• Newman B. Safety first. Nurs Rev. 2010, June:26.
   Google Scholar
• Australian Institute of Health and Welfare (AIHW). Australian Hospital Statistics 2007–8. Canberra: AIHW; 2009.
   Google Scholar
• Stowasser D, Allinson Y, O’Leary D. Understanding the medicine management pathway. J Pharm Pract Res. 2004;34:293–6. doi: 10.1002/jppr2004344293
   Google Scholar
• Australian Commission on Quality and Safety in Health Care. 2010. http://www.health.gov.au/internet/safety/publishing.nsf/Content/NIMC_005_Medication-Safety-Alerts (accessed May 2010).
   Google Scholar
• Rommers M, Teepe-Twiss I, Guchelaar H-J. Preventing adverse drug events in hospital practice: an overview. Pharmacoepidem Dr S. 2007;16:1129–35. doi: 10.1002/pds.1440
   Google Scholar
• Dooley M, Wiseman M, McRae A, Murray D, Van De Vreede M, Topliss D, et al. Reducing potentially fatal errors associated with high doses of insulin: a successful multifaceted multidisciplinary prevention strategy. BMJ Qual Saf. 2011;20(7):637–44. (accessed December 2011). doi: 10.1136/bmjqs.2010.049668
   Google Scholar
• Fowler D, Rayman G. Safe and effective use of insulin in hospitalised patients. London: National Health Service; 2010. http://www.diabetes.nhs.uk/document.php?o=1040 (accessed January 2011).
   Google Scholar
• National prescribing service. NPS Medicinewise Older, wiser, safer. 2013. www.org.au/aolder -people
   Google Scholar
• Bain S, Druyts E, Balijepalli C, Baxter C, Currie CJ, Das R, et al. Cardiovascular events and all-cause mortality associated with suplhonylureas compared to other antihyperglycaemic drugs: a Bayesian met-analysis of survival data. Diabetes Obes Metab. 2017;19(3):329–35. doi: 10.1111/dom.12821
   Google Scholar
• Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of US concensus panel of experts. Arch Intern Med. 2003;163:2716–24. doi: 10.1001/archinte.163.22.2716
   Google Scholar
• Budnitz D, Lovegrove M, Shehab N, Richards C. Emergency hospitalizations for adverse drug events in older Americans. New Engl J Med. 2011;365(21):2002–12. doi: 10.1056/NEJMsa1103053
   Google Scholar
• Ernst E. Global prevalence of complementary medicines. World Health Organ Bull. 2000;78(2):252–57.
   Google Scholar
• Egede LE, Ye X, Zheng D, Silverstein MD. The prevalence and pattern of complementary and alternative medicine use in individuals with diabetes. Diabetes Care. 2002;25:324–9. doi: 10.2337/diacare.25.2.324
   Google Scholar
• Dunning T. Complementary therapies and diabetes. Complement Ther Nurs Midwifery. 2003;9:74–80. doi: 10.1016/S1353-6117(02)00143-9
   Google Scholar
• Manya K, Champion B, Dunning T. The use of complementary and alternative medicine among people living with diabetes in Sydney. BMC Complem Altern M. 2012. doi:10.1166/1472-6882-12-2.
   Google Scholar
• Bodenheimer T, Lorig K, Holman H, Grumbach K. Patient self-management of chronic disease in primary care. J Am Med Assoc. 2002;288(19):2469–75. doi: 10.1001/jama.288.19.2469
   Google Scholar
• Haynes R, Yao X, Degani A, Kripalani S, Garg A, McDonald H. Interventions for enhancing medicine adherence. Cochrane Database Syst Rev Issue 4, ART No: CD000011. 2005. doi.10.1002/14651838.CD000011.pub2.
   Google Scholar
• World health Organisation (WHO). Adherence to long-term therapies: evidence for action. Geneva: WHO; 2003.
   Google Scholar
• Cramer J, Roy A, Burrell A, Fairchild C, Fuldeore M, Ollendorf D, et al. International Society for Pharmacoeconomics for Outcomes Research Working Group. Medication compliance and persistence: terminology and definitions. Value Health. 2007;11(1):4447.
   Google Scholar
• Segal J. ‘Compliance’ to ‘Concordance’: a critical view. J Med Humanit. 2007;28:81–96. doi: 10.1007/s10912-007-9030-4
   Google Scholar
• Bissonnette J. Adherence: a concept analysis. J Adv Nurs. 2008;63(6):634–43. doi: 10.1111/j.1365-2648.2008.04745.x
   Google Scholar
• Pound P, Bitten N, Morgan M, Yardley L, Pope C, Daker-White G, et al. Resisting medicines: a synthesis of qualitative studies of medicine taking. Soc Sci Med. 2005;61:133–55. doi: 10.1016/j.socscimed.2004.11.063
   Google Scholar
• Britten N. Commentary: does a prescribed treatment match a patient’s priorities? Brit Med J. 2003;327:840. doi: 10.1136/bmj.327.7419.840
   Google Scholar
• Brian Haynes R, Ann McKibbon A, Kanani R. Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications. Lancet. 1996;348:383–6. doi: 10.1016/S0140-6736(96)01073-2
   Google Scholar
• Di Matteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care. 2002;40(9):794–11. doi: 10.1097/00005650-200209000-00009
   Google Scholar
• Simpson S, Eurich D, Radjeedp S, Ross I, Varney J, Johnson J. A meta-analysis of the association between adherence to drug therapy and mortality. Brit Med J. 2006;333:15–8. doi: 10.1136/bmj.38875.675486.55
   Google Scholar
• Bieszk N, Patel R, Heaberlin A. Detection of medication non-adherence through review of pharmacy claims data. Am J Health-Syst PH. 2003;15(60):360–6.
   Google Scholar
• Kerse N, Buetow S, Mainous A, Young G, Coster G, Arroll B. Physician–patient relationship and medication compliance: a primary care investigation. Ann Fam Med. 2004;2(5):455–61. doi: 10.1370/afm.139
   Google Scholar
• Yang Y, Dunning T, Rasmussen B. Chinese people’s experience of diabetes self-care in Australia. Diabetes Conquest. Summer: 2011:9–10.
   Google Scholar
• Choudhry N, Fletcher R, Soumerai SB. Systematic review: the relationship between clinical experience and quality of health care. Ann Intern Med. 2005;142:260–73. doi: 10.7326/0003-4819-142-4-200502150-00008
   Google Scholar
• The Pharmacy Guild of Australia. Medindex: a medicine compliance indicator. Canberra: The Pharmacy Guild of Australia; 2010. Http://www.medsindex.com.au (accessed November 2011).
   Google Scholar
• Williams A, Manias E, Walker R. Interventions to improve medication adherence in people with multiple chronic conditions: a systematic review. J Adv Nurs. 2008;63(2):132–43. doi: 10.1111/j.1365-2648.2008.04656.x
   Google Scholar